In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...